Trial Profile
An observational, retrospective trial to evaluate the efficacy and safety of low-dose etanercept in patients with ankylosing spondylitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Apr 2016
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 13 Apr 2016 New trial record
- 25 Mar 2016 Results (n=134) published in the Clinical and Experimental Rheumatology.